Ep 28: Unlocking the Secrets of Cancer: The Role of Omics
Release Date: 06/02/2025
Ep 56: How At-Home Lab Testing Works (Behind the Kit)
Boombostic Health
At-home diagnostics isn’t “a kit.” It’s an operating system. From the outside, it looks simple: order → kit arrives → collect → mail back. Behind the scenes, scaling that experience requires automation, reliability, and speed. In this conversation, Jeff Shattuck explains how DOT Corp uses automation, robotics, and AI to reduce the time from order to shipment, expanding what’s possible for home diagnostics and precision medicine. Key moments DotCorp transitioned from printing to healthcare logistics. AI and robotics are streamlining healthcare processes. At-home testing is...
info_outline
Ep 55: Stigma is a barrier. At-home testing breaks it. HIV + STI Testing.
Boombostic Health
Show Notes Healthcare keeps talking about AI, affordability, and outcomes… But most systems are still ignoring the front door that drives care decisions: diagnostics. Recorded In the Wild at HLTH 2025 in Las Vegas, Bradley Bostic sits down with James York (Chief Commercial Officer + Head of Government Affairs, Molecular Testing Labs) to unpack a hard truth: If you can’t make testing accessible, convenient, and trackable… you can’t build reliable care pathways. In this episode, James breaks down why diagnostics is a flywheel—the top-of-funnel that activates patients—and why “we...
info_outline
Ep 54: The Business of Making Healthcare Data Trustworthy
Boombostic Health
Summary Healthcare is racing to be “AI ready.” But most of the industry is still trying to turn billing exhaust into strategy. In this episode, Bradley Bostic sits down with Ryan Leurck, Co-Founder & Chief Analytics Officer at Kythera Labs, to cut through the noise and get blunt about what actually makes AI work in healthcare. Because the truth is simple—and uncomfortable: If your data can’t be trusted by humans, it can’t be trusted by AI. And in healthcare, much of our data was never designed for the questions we’re now demanding it answer. Takeaways Why claims, EHR, and lab...
info_outline
Ep 53: Screening for Dementia with AI - Your Brain’s Early Warning System
Boombostic Health
Summary By the time most people hear “dementia,” their brain has been sounding the alarm for years. In this episode of Boombostic Health, Dr. John Showalter shares his journey from internist to healthcare technology innovator. He explains how AI and digital tools can support early detection and intervention for cognitive decline—before daily life starts to fall apart. The conversation highlights how lifestyle changes can improve cognitive health, why screening the brain should be as routine as checking blood pressure, and how integrating technology into healthcare systems can scale...
info_outline
Ep 52: Mental Health, Cancer, and the Gut Data We’re Not Using
Boombostic Health
We talk a lot about “data-driven healthcare,” yet we’re still blind to one of the most important data layers: the microbiome. Mental health, early-onset cancer, autoimmunity—much of that risk is already visible in the gut years before a diagnosis code ever hits the chart. Most care models, benefits designs, and longevity strategies simply don’t account for it. In this episode of Boombostic Health, I sit down with Paul Denslow, CEO & co-founder of Intus Bio, to dig into how GutID turns the microbiome into hard infrastructure: high-resolution gut data, a score you can track, and a...
info_outline
Ep 51: AI Can’t Fix Virtual Care’s 70% Lab Problem
Boombostic Health
Virtual care is scaling. AI is everywhere. But when lab completion falls from ~70% in-clinic to ~30% in virtual care, the whole model breaks. Virtual Care Without Labs Is Just Zoom - Even with AI. In this Boombostic Health in the Wild episode from HLTH 2025, Bradley Bostic sits down with Maitham Dib, founder of Junction, to unpack the "real" bottleneck: turning lab orders into lab results. They dig into how Junction: * White-labels lab infrastructure so any virtual or hybrid care model can deploy labs across all 50 states * Uses data from ~3.4 million lab...
info_outline
Ep 50: 95% of Care From Home: The Virtual Model Changing Healthcare
Boombostic Health
Virtual care isn’t a feature. It’s the future care model nobody in healthcare wants to admit is already here. At HLTH 2025, we sat down with Michael Dalton, CEO and founder of Ovatient, to unpack the real story behind why rural and urban patients alike are falling through the cracks and how Ovatient built the first truly integrated virtual multi-specialty practice on Epic. This conversation exposes three uncomfortable truths in healthcare: Access is still broken. Millions delay care because transportation, work schedules, stigma, or geography get in the way. Telemedicine wasn’t...
info_outline
Ep 49: The Real Healthcare Disruption Isn’t AI - It’s Your DNA
Boombostic Health
AI will accelerate healthcare — but genomics will rewrite it. The minute DNA drives care decisions for everyone, the current system becomes obsolete. Gene by Gene quietly runs one of the most advanced, high-throughput genomics labs in the world — powering platforms like MyHeritage and rapidly transforming clinical medicine, oncology, pharmacogenomics, and ancestry. This conversation explores what happens when every person leaves the hospital with a genomic passport — a lifelong DNA profile they own, control, and use to prevent disease before it begins. This is preventive medicine...
info_outline
Ep 48: Time to Treatment Accelerating the Connection to Care
Boombostic Health
Pharma Isn’t Broken — Access Is ixlayer x Sanofi Ventures @ HLTH 2025 Patients don’t suffer because we lack medical innovation — they suffer because it takes too long to access it. 🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it. The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers: How digital...
info_outline
Ep 47: Fixing Prescription Costs with E-Prescribing and Transparency
Boombostic Health
Prescription costs are broken — and patients are the ones paying the price. In this episode of Boombostic Health, host Bradley Bostic sits down with Lathe Bigler of First Data Bank to unpack why e-prescribing hasn’t evolved in decades, how opaque pricing keeps patients in the dark, and why the next wave of pharmacy network innovation could flip the power dynamic back to patients. 💡 What We Cover: Why patients are frustrated with rising prescription costs How transparency empowers patients with real choices What most people don’t know about paying cash for prescriptions How...
info_outlineSummary
In this episode of Boombostic Health, Bradley Bostic interviews Dustin Suntheimer, Director of Commercial Operations in diagnostics, to discuss the advancements in oncology testing and the impact of genetic profiling on cancer treatment.
They explore the evolution of cancer diagnostics, the significance of omics, and the role of advanced genetic testing in personalizing treatment plans. The conversation also touches on the accessibility of these tests across different demographics and the future of cancer care, emphasizing the importance of collaboration between healthcare providers and laboratories.
Watch full episode on YouTube here
Takeaways
- The state of oncology testing has significantly improved over the years.
- Advanced molecular assays can lead to better patient outcomes.
- Digital pathology allows for remote examination of tissue samples.
- Genetic testing can help eliminate ineffective treatments.
- Molecular profiling is essential for personalized cancer therapy.
- Omics encompasses various fields that enhance our understanding of biology.
- Precision medicine tailors treatment based on individual genetic profiles.
- Genetic testing should be accessible to all patients, regardless of socioeconomic status.
- Healthcare providers must be aware of genetic testing guidelines.
- Collaboration between physicians and laboratories is crucial for patient care.
Chapters
00:00 Introduction to Oncology Testing and Its Evolution
03:01 Understanding Anatomic Pathology and Molecular Testing
06:00 The Importance of Genetic Profiling in Cancer Treatment
08:55 The Role of Omics in Cancer Diagnostics
11:52 Advanced Technologies in Cancer Testing
14:54 The Impact of Genetic Testing on Preventative Care
17:49 Tracking Cancer Recurrence with Advanced Testing
21:00 The Importance of Family History in Cancer Risk
24:05 Guidelines for Genetic Testing and Preventative Measures
26:55 Healthcare Innovation and the Future of Cancer Treatment
29:55 The Socioeconomic Factors in Accessing Genetic Testing
33:08 Conclusion and Future Directions in Oncology